Preparation and application of anti-tumor bifunctional fusion proteins

Details for Australian Patent Application No. 2004252465 (hide)

Owner Oncomax Acquisition Corp.

Inventors Guo, Yajun; Ma, Jing

Agent Spruson & Ferguson

Pub. Number AU-A-2004252465

PCT Pub. Number WO2005/001048

Priority 10/723,003 26.11.03 US; 03129290.9 13.06.03 CN; 2003101199300 25.11.03 CN; 092133577 28.11.03 TW

Filing date 4 June 2004

Wipo publication date 6 January 2005

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/001048 Priority application(s): WO2005/001048

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004252475-Modulating the interaction between HGF beta chain and c-met

2004252460-Plant fatty acid amide hydrolases